Live
IlluminaIllumina Inc. stock faces renewed scrutiny amid Grail divestiture delays and biotech sector headwind - AD HOC NEWSThermo FisherIs Thermo Fisher Scientific (TMO) Pricing Look Attractive After Recent Share Price Weakness - Yahoo FinanceAgilentAgilent Technologies Advances Chromatography Innovations for Pharma and Biotech in 2026 - AD HOC NEWSLonza NewsLonza Group AG Stock Faces Pressure Amid Biopharma Sector Slowdown and Capacity Utilization Concerns - AD HOC NEWSCellThe BMP Inhibitor Coco Reactivates Breast Cancer Cells at Lung Metastatic SitesWatersSwiss Life Asset Management Ltd Buys 3,789 Shares of Waters Corporation $WAT - MarketBeatIlluminaSwiss Life Asset Management Ltd Purchases 67,772 Shares of Illumina, Inc. $ILMN - MarketBeatThermo FisherSarasin & Partners LLP Decreases Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeatLonza NewsLonza Group AG stock faces pressure amid biotech slowdown as of March 2026 - AD HOC NEWSLonza NewsNature of Things: Lonza, antibodies and Solano County’s biotech future - Daily Republic10x Genomics BlogHow ARK’s TXG Selloff and Cautious 2026 Outlook Will Impact 10x Genomics (TXG) Investors - simplywall.st10x Genomics BlogHow ARK’s TXG Selloff and Cautious 2026 Outlook Will Impact 10x Genomics (TXG) Investors - simplywall.st
Endpoints News Jan 14, 2026

#JPM26: Q&A with Bristol Myers Squibb CEO Chris Boerner on 2026 outlook

#JPM26: Q&A with Bristol Myers Squibb CEO Chris Boerner on 2026 outlook

Original
Body unavailable. Use the original source.

Directory

59 All